The global continuous passive motion devices market was valued at USD 814.4 million in 2023 and is expected to grow at a CAGR of 5.2% from 2024 to 2030. This growth can be attributed to the rising prevalence of orthopedic disorders, such as knee replacement surgeries and ligament reconstruction. Patients have increasingly sought CPM devices as they help prevent joint stiffness and enhance range of motion after orthopedic surgery on joints including the knee, hip, ankle, and shoulder.
CPM therapy is a non-invasive, drug-free method for managing pain and improving joint mobility after surgery. Advanced CPM devices can be effectively operated at home and in outpatient settings for enhanced postoperative rehabilitation while maintaining cost effectiveness. The market has witnessed a considerable rise in demand for CPM devices as patients have become increasingly aware of these benefits, thereby contributing to market growth.
Furthermore, the development of portable and lightweight designs have made CPM devices more practical and user-friendly, leading to widespread adoption. Such characteristics enable users to ensure proper motion of limbs as the first stage of rehabilitation following the traumas and soft tissue medical procedure. Moreover, the U.S. Food and Drug Administration (FDA) and Europe Medicine Agency (EMA) have approved several CPM devices for clinical and home care use. Stringent regulations ensure patient safety and treatment efficacy.
Knee joint CPM devices have secured the dominant market share with 41.3% in 2023 owing to their widespread adoption after knee arthroplasty, ACL reconstruction, and other knee surgeries for outpatient knee rehabilitation. These devices facilitate controlled, repetitive motion, prevent muscle stiffness and promote healing by enhancing blood flow and nutrient diffusion. They also allow elderly patients to maintain joint mobility without active effort, reducing pain and swelling. Furthermore, the increasing penetration of rehabilitation services and government regulations have considerably increased patient adoption of knee joint CPM devices.
Hip joint CPM devices are expected to register the fastest CAGR over the forecast period. The rising number of joint reconstruction surgeries, including hip replacements, have propelled the market growth as these devices are widely used after hip arthroplasty and other hip surgeries. Patients with limited mobility benefit from passive motion as they can control their motion without active effort.
Portable devices have dominated the market in 2023 and is projected to grow lucratively over the forecast period due to their rising adoption for enhanced recovery process for patients. The market has witnessed a major shift towards home-based care driven by patient preference for cost-effectiveness. This has led patients to easily operate these devices at home for continued therapy beyond hospital stays. Such convenience of using these devices promotes consistent rehabilitation, leading to faster recovery times. Moreover, innovations in materials, miniaturization, and wireless connectivity in portable devices including wearable sensors, mobile apps, and cloud-based data storage have enhanced patient monitoring. This has resulted in the huge adoption of smart CPM devices which incorporate real-time monitoring and precise motion control, preventing joint stiffness. These devices adapt to individual needs, optimizing therapy parameters based on patient progress.
Fixed CPM devices are anticipated to emerge at the fastest-growing CAGR of 4.2% over the forecast period. These devices offer consistent, controlled motion without user intervention, ensuring reliable therapy. Their safe implementation encourages adoption among patients and healthcare providers. Additionally, fixed devices are versatile and are applied beyond joint surgeries, including osteoarthritis, fractures, and trauma-related injuries.
Adults have led the market with the dominant share of 57.0% in 2023 owing to the increasing prevalence of joint replacement surgeries, such as knee and hip arthroplasty among the geriatric population. With the growing elderly population, joint-related conditions such as loss of bone mass and density have become more common, necessitating post-surgical rehabilitation and promoting CPM adoption. Additionally, trauma-related injuries and ligament reconstruction surgeries contribute to the need for joint rehabilitation. CPM therapy aids recovery by providing controlled motion without active effort.
Children (below 18) are projected to emerge at the fastest CAGR over the forecast period. Pediatric joint surgeries, such as ACL reconstruction or fracture repair, have considerably driven demand for CRM devices as children with orthopedic disorders or post-surgical needs benefit from CPM therapy. Moreover, the increasing awareness about post-surgical rehabilitation among parents and healthcare providers have resulted in major adoption of pediatric-focused CPM devices These devices ensure gentle, controlled motion without causing harm to young patients.
The North America CPM devices market accounted for the dominant share of 47.3% in 2023 owing to the increasing prevalence of musculoskeletal disorders, such as osteoarthritis and joint-related conditions. Furthermore, technological advancements led to several innovations in CPM device design, portability, and safety that enhanced adoption rates.
The CPM devices market in the U.S. was significantly propelled by the rising number of joint reconstruction surgeries, particularly for knee and hip arthroplasty among the growing geriatric population. These devices play a crucial role in post-surgical rehabilitation, preventing muscle stiffness and enhancing joint mobility. CPM devices cater to older adults who benefit from passive motion therapy after joint surgeries. Additionally, adherence to U.S. FDA regulations to ensure device safety and efficacy has fostered market trust and increased adoption.
The Europe CPM devices market held 24.7% of the global revenue share in 2023 owing to the rising awareness about the benefits of non-invasive post-operative therapy. CPM devices offer drug-free therapy for managing pain and enhancing joint mobility with repetitive motion to prevent joint stiffness in ankle, shoulder, hip and knee.
The CPM devices market in Asia Pacific (APAC) region secured 17.6% of the share in 2023. The region witnessed a surge in joint reconstruction surgeries, including knee and hip arthroplasty owing to the aging population and the growing lifestyle-oriented orthopedic conditions. Moreover, innovations in CPM device design, safety features, and user-friendliness have encouraged remote patient monitoring, thereby driving market adoption rates.
The continuous motion devices market is fairly fragmented featuring key players including The Furniss Corporation, Surgi-Care Inc.; BTL Corporate, and others. These companies strive to dominate the market by undertaking advanced product development, strategic partnerships and increased R&D efforts.
The Furniss Corporation is a medical manufacturer specializing in CPM devices. The company guarantees a 3-day turnaround on technical service repairs and offers to rent virtually unlimited Knee CPMs. Their durable, user-friendly devices are built to withstand rigorous hospital and home care environments.
Surgi-Care, Inc., based in New England, is a leading supplier of orthopedic surgical products, medical devices, and services. They offer a range of products, including sports medicine implants, surgical instrumentation, orthopedic braces, and CPM equipment. Surgi-Care partners with innovators including DJO Global and provides same-day shipping, access to educated product professionals, and strong product lines.
The following are the leading companies in the continuous passive motion devices market. These companies collectively hold the largest market share and dictate industry trends.
In November 2023, Salona Global, soon to be renamed Evome Medical Technologies, launched Biodex SpaceTek Knee Device -- a novel portable medical device designed to treat patients with knee replacements and injuries. This product was developed in collaboration with the National Aeronautics and Space Administration (NASA) specifically designed for use in outer space. It leverages technology similar to that of the Biodex S4 isokinetic machine with dynamometers.
In March 2023, HMS Medical Systems introduced KNEEFLEX Es Continuous Passive Motion (CPM) equipment. This device enhances precision, safety, and efficiency for patients and healthcare professionals. The KNEEFLEX Es facilitates knee mobility recovery by utilizing advanced algorithms to deliver consistent and accurate motion, crucial for optimal rehabilitation outcomes.
Report Attribute |
Details |
Market size value in 2024 |
USD 854.2 million |
Revenue forecast in 2030 |
USD 1.2 billion |
Growth rate |
CAGR of 5.2% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
September 2024 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, design, demographics, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, Thailand, South Korea, Brazil, Argentina, South Africa, Kuwait, Saudi Arabia, UAE |
Key companies profiled |
The Furniss Corporation Ltd.; Surgi-Care, Inc.; Bio-Med International Pvt Ltd.; CHINESPORT Spa Cap. (Chinesport Rehabilitation); BTL Corporate; Chattanooga (DJO, LLC); Biodex; Kinetec UK; Kinex Medical Company, LLC; HMS Medical Systems |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global continuous passive motion devices market report based on type, design, demographics, and region:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Knee Joint CPM Devices
Shoulder Joint CPM Devices
Hip Joint CPM Devices
Ankle Joint CPM Devices
Others
Design Outlook (Revenue, USD Million, 2018 - 2030)
Portable Devices
Fixed Devices
Demographics Outlook (Revenue, USD Million, 2018 - 2030)
Children (Below 18)
Adult (18 and above)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."